Article
Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy
2020-08-17
Abstract excerpt
<title>Abstract</title> <p>Treatment with molecularly-targeted therapy has revolutionized cancer care, including BRAF/MEK-targeted melanoma therapy. However responses are heterogenous and frequently not long-lasting. Novel strategies to target resistance are needed. We studied a cohort of patients with resectable metastatic melanoma treated with neoadjuvant BRAF/MEK-targeted therapy (n=52) and noted a strong sexu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 46f93f44-13c8-5482-bf47-225132b6593d
- DOI
- 10.21203/rs.3.rs-58480/v1
